Montelukast fast dissolve tablet - SamyangAlternative Names: Montelukast FDT - Samyang
Latest Information Update: 22 Apr 2015
At a glance
- Originator Samyang Biopharmaceuticals Corporation; Samyang Group
- Developer Samyang Biopharmaceuticals Corporation
- Class Acetates; Antiasthmatics; Quinolines; Small molecules
- Mechanism of Action Leukotriene D4 receptor antagonists
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
On Fast track
Fast track status is assigned by the US FDA so therapies with the potential to address unmet needs can move faster through development.
- New Molecular Entity No
Highest Development Phases
- No development reported Asthma
Most Recent Events
- 15 Mar 2016 Biomarkers information updated